Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA saw early reports of severe Omontys reactions: WSJ
FDA saw early reports of severe Omontys reactions: WSJ
FDA saw early reports of severe Omontys reactions: WSJ
Submitted by
admin
on April 1, 2013 - 11:20am
Source:
Fierce Pharma
News Tags:
FDA
Omontys
Affymax
anemia
Takeda
Headline:
FDA saw early reports of severe Omontys reactions: WSJ
Do Not Allow Advertisers to Use My Personal information
